Arima Genomics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
47
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$22M
- Investors
-
18
Arima Genomics General Information
Description
Developer of a gene-sequencing technology designed to accelerate the understanding of genome sequence and structure toward their role in human health and disease. The company's technology is a proximity ligation method that captures the three-dimensional organizational structure of chromatin, where genomic sequences that are closer to each other in the 3D space can be distal to each other in linear distance, thereby preserving long-range sequence and structure information before sequencing, enabling scientists to identify structural variants of genes and allowing the analysis of critical genetic information.
Contact Information
Website
www.arimagenomics.comCorporate Office
- 6404 Nancy Ridge Drive
- San Diego, CA 92121
- United States
Corporate Office
- 6404 Nancy Ridge Drive
- San Diego, CA 92121
- United States
Arima Genomics Timeline
Arima Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Later Stage VC (Series C) | 17-Jun-2025 | $22M | Completed | Generating Revenue | ||
| 16. Grant | 01-May-2023 | Completed | Generating Revenue | |||
| 15. Later Stage VC (Series B) | 22-Jan-2022 | Completed | Generating Revenue | |||
| 14. Grant | 05-Apr-2021 | Completed | Generating Revenue | |||
| 13. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 12. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 10. Debt - PPP | 12-Apr-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series A) | 24-Feb-2020 | $3.7M | $3.7M | Completed | Generating Revenue | |
| 8. Grant | 01-Jan-2020 | $2M | Completed | Generating Revenue |
Arima Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 4,850,000 | $0.000100 | 8% | $0.77 | $0.77 | 1x | $0.77 | 6.74% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Arima Genomics Comparisons
Industry
Financing
Details
Arima Genomics Competitors (10)
One of Arima Genomics’s 10 competitors is Acuity Spatial Genomics, a Corporate Backed or Acquired company based in Santa Barbara, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Acuity Spatial Genomics | Corporate Backed or Acquired | Santa Barbara, CA | ||||
| Quantapore | Venture Capital-Backed | South San Francisco, CA | ||||
| Ozette | Venture Capital-Backed | Seattle, WA | ||||
| Sphere Fluidics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| CosmosID | Formerly VC-backed | Germantown, MD |
Arima Genomics Patents
Arima Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026080845-A1 | Genetic alteration detection | Pending | 10-Oct-2024 | ||
| WO-2025199450-A1 | Methods of selecting and treating cancer subjects that are candidates for treatment using inhibitors of a pd-1 pathway | Pending | 22-Mar-2024 | ||
| EP-4731779-A2 | Methods and compositions for preparing extracellular vesicle nucleic acids that preserve spatial-proximity information and applications thereof | Pending | 21-Jun-2023 | ||
| WO-2024263946-A2 | Methods and compositions for preparing extracellular vesicle nucleic acids that preserve spatial-proximity information and applications thereof | Inactive | 21-Jun-2023 | ||
| WO-2024263946-A3 | Methods and compositions for preparing extracellular vesicle nucleic acids that preserve spatial-proximity information and applications thereof | Inactive | 21-Jun-2023 | C12Q1/6886 |
Arima Genomics Signals
Arima Genomics Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Phase Two Ventures | Venture Capital | Minority | ||
| Genetron Health | Corporation | Minority | ||
| Hiaqua Investments | Venture Capital | Minority |
Arima Genomics Investments (1)
Arima Genomics’s most recent deal was a Joint Venture with Aventa. The deal was made on 31-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aventa | 31-Jan-2023 | Joint Venture | Biotechnology |
Arima Genomics FAQs
-
When was Arima Genomics founded?
Arima Genomics was founded in 2015.
-
Where is Arima Genomics headquartered?
Arima Genomics is headquartered in San Diego, CA.
-
What is the size of Arima Genomics?
Arima Genomics has 47 total employees.
-
What industry is Arima Genomics in?
Arima Genomics’s primary industry is Biotechnology.
-
Is Arima Genomics a private or public company?
Arima Genomics is a Private company.
-
What is the current valuation of Arima Genomics?
The current valuation of Arima Genomics is .
-
What is Arima Genomics’s current revenue?
The current revenue for Arima Genomics is .
-
How much funding has Arima Genomics raised over time?
Arima Genomics has raised $32.7M.
-
Who are Arima Genomics’s investors?
, , Phase Two Ventures, Genetron Health, and Hiaqua Investments are 5 of 18 investors who have invested in Arima Genomics.
-
Who are Arima Genomics’s competitors?
Acuity Spatial Genomics, Quantapore, Ozette, Sphere Fluidics, and CosmosID are some of the 10 competitors of Arima Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process